Inhibition of Olig2 Activity
Copyright © Targeted News Service 2024
2024-11-19
ALEXANDRIA, Virginia, Nov. 19 -- CURTANA PHARMACEUTICALS, INC., Austin, Texas has been assigned a patent (No. US 12145913 B2, initially filed April 19, 2021) developed by five inventors Graham Beaton, San Diego, California; Stanton F. McHardy, Waring, Texas; Ambrosio Lopez, Jr., San Antonio, Texas; Bismarck Campos, San Antonio, Texas; and Hua-Yu Leo Wang, San Antonio, Texas, for "Inhibition of Olig2 activity." . . .